Company Filing History:
Years Active: 2012
Title: Rainer Oelze: Innovator in Cardiovascular Health
Introduction
Rainer Oelze is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of cardiovascular health through his innovative research and patenting efforts. His work focuses on the treatment and inhibition of depression in patients suffering from coronary heart or artery disease.
Latest Patents
Rainer Oelze holds a patent for a method of treating or inhibiting depression in patients with cardiovascular disease. This patent, titled "Essential fatty acids in the treatment and/or inhibition of depression in patients with coronary heart or artery disease," outlines a method that includes administering a therapeutically effective amount of an essential fatty acid composition. This composition comprises more than 25% by weight of eicosapentanoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester (DHA), or a mixture of both. The method specifies an EPA/DHA ratio in the range from about 0.9 to about 1.5, with a recommended dosage of from about 0.7 g to about 6 g per day.
Career Highlights
Rainer Oelze is currently associated with Abbott Products GmbH, where he continues to advance his research in the medical field. His work has been instrumental in developing new therapeutic approaches for patients with cardiovascular issues.
Collaborations
Rainer Oelze collaborates with Cees-Nico Verboom, contributing to the advancement of their shared research interests in cardiovascular health.
Conclusion
Rainer Oelze's innovative work in the treatment of depression related to cardiovascular disease highlights the importance of essential fatty acids in medical therapies. His contributions through patenting and collaboration continue to pave the way for advancements in healthcare.